- Видео 36
- Просмотров 124 461
MERIT CRO
Добавлен 27 май 2021
MERIT is an innovative clinical endpoint expert providing attentive expertise in our therapeutic areas. We partner with CROs, pharma, and biotech companies to deliver reliable endpoint services in global clinical trials. Together our work advances and accelerates the improvement of therapeutic options for patients worldwide.
We have a proven track record providing endpoint expertise to 12 of the top 20 global pharmaceutical companies. We prioritize a collaborative, partnership-driven approach for all projects with scalable solutions and personalized attention. If you’re looking for a partner that will bring dedication and expertise to your clinical trial, consider MERIT.
We have a proven track record providing endpoint expertise to 12 of the top 20 global pharmaceutical companies. We prioritize a collaborative, partnership-driven approach for all projects with scalable solutions and personalized attention. If you’re looking for a partner that will bring dedication and expertise to your clinical trial, consider MERIT.
EXCELSIOR Racecar Video
MERIT's EXCELSIOR software has turbo charged more ophthalmology clinical trials than any other platform. Choose EXCELSIOR to win your race! Learn more about our proprietary cloud-based software solution: meritcro.com/imaging-software/?
Просмотров: 21
Видео
MERIT: Your Clinical Endpoint Expert
Просмотров 423 месяца назад
Interested in a succinct overview of MERIT's expertise and services? Amanda Weber, Partnerships Manager, provides insight into our clinical endpoint analysis in this short video clip. Learn more about our services: meritcro.com/general-lp/?
What Makes EXCELSIOR Software Unique?
Просмотров 413 месяца назад
Anne Goulding, MERIT's Director of Ophthalmology Account Management, and Nathan Diers, VP of Product Development, provide an overview of our EXCELSIOR imaging software's key differentiators. Learn more about EXCELSIOR: meritcro.com/imaging-software/?
EXCELSIOR Software Advantages
Просмотров 223 месяца назад
EXCELSIOR software allows users to view study progress and data in a transparent, secure environment. Analyzing trends in the platform enables MERIT to stay ahead of challenges. Learn more about the advantages of EXCELSIOR in this video. Explore how EXCELSIOR simplifies complex studies: meritcro.com/imaging-software
EXCELSIOR Software Client Benefits
Просмотров 413 месяца назад
MERIT's EXCELSIOR™ technology platform increases accuracy and efficiency by providing a suite of advanced endpoint analysis tools designed based on our extensive collaboration with biopharma companies. With MERIT your study data and images can easily be shared between clinical sites, reading centers, CROs, and Sponsors for maximum transparency. This makes managing global trials involving multip...
MERIT's Respiratory Expertise & Site Support
Просмотров 683 месяца назад
What if you could fully-engage sites in every stage of a respiratory clinical trial from startup to conductance to closeout so that your next study completed ahead of time and under budget? We know trials are a marathon and not a sprint, and that means sites must be fully engaged in every stage of a study. MERIT’s standardized processes and training, easy-to-use data platform, and continuous da...
Common Challenge with Reader Monitoring Plans
Просмотров 314 месяца назад
Our ophthalmology webinar “Effective Reader Monitoring Plans & Variability QC for ADC, Immuno-Oncology, Cancer Cell Therapy & Radiopharmaceutical Studies” spawned some great discussion. Watch a short clip from the webinar video where Dr. Lin, Associate Medical Director at MERIT, answers the participant question, “What is a common challenge you’ve encountered when implementing reader monitoring ...
Effective Reader Monitoring Plans & Variability QC for ADC, IO, CAR-T & Radiopharmaceutical Studies
Просмотров 625 месяцев назад
Maintaining consistency and data integrity in imaging assessment can be very challenging in studies with imaging outcomes. There are various sources of variability in imaging assessment, particularly when qualitative assessment is involved in the reading process. In this MERIT webinar, we discuss assessor variability and using reader monitoring plans to mitigate data variability in oncology cli...
OCT Imaging with EXCELSIOR
Просмотров 916 месяцев назад
In our EXCELSIOR software platform we typically use the DICOM standard, and that is by far able to give us the best ability to take measurements and to interpret the different modalities - regardless of whether you're talking about Optical Coherence Tomography (OCT) or something else. If the Sponsor is not able to provide us with DICOM images, we can still manage those. Dr. Shawn Wilker, MERIT'...
EXCELSIOR Software Modalities
Просмотров 496 месяцев назад
In addition to Optical Coherence Tomography (OCT), what other modalities can be uploaded and graded within MERIT's EXCELSIOR software platform? Dr. Shawn Wilker, MERIT's Medical Director of Ophthalmology, provides insight into the different modalities that are supported. This includes color photographs, fluorescein angiograms, ICG, autofluorescence, VEP, etc. Learn more in this short video clip...
Can AI be used for the interpretation of OCTs?
Просмотров 316 месяцев назад
Artificial Intelligence is on the forefront of a lot of people's minds. In the world of ophthalmology, there is a lot of research going on right now with AI, specifically, with diabetic retinopathy, systems that are able to count micro aneurysms, or give a diabetic retinopathy severity score. In the macular degeneration world, looking for subretinal fluid or some sort of home test that you can ...
MERIT Webinar: OCT Evaluation of Neovascular AMD in Clinical Trials - A Reading Center Perspective
Просмотров 1818 месяцев назад
This video provides an overview of the role a reading center plays in the use of Optical Coherence Tomography (OCT) in major studies for patients with neovascular Age-related Macular Degeneration (nAMD). MERIT experts review the capabilities of the reading center and summarize how these studies are approached. 3 key questions that are answered: 1) What benefits does a reading center offer Spons...
MERIT Webinar: Understanding Pseudoprogression - Navigating Neuro-Oncology
Просмотров 3509 месяцев назад
Most brain cancer diagnoses in the United States are glioma, and our upcoming webinar will explore the challenges and potential solutions for assessing these tumors. These primary brain tumors can present in the form of gliomas (both low-grade glioma and glioblastoma). Oftentimes glioma can be debilitating to patients with a poor prognosis and limited treatment. New therapies are being studied ...
MERIT's EXCELSIOR Software Overview & Key Features
Просмотров 6910 месяцев назад
Ron Danis, MD, Chief Scientific Officer at MERIT, and Pete Cueno, Product Operations Manager at MERIT, provide an overview of MERIT's EXCELSIOR software platform. Learn more about EXCELSIOR: meritcro.com/imaging-software/?
EXCELSIOR Software Benefits
Просмотров 3810 месяцев назад
MERIT’s EXCELSIOR technology platform increases accuracy and efficiency by providing a suite of advanced endpoint analysis tools designed based on our extensive collaboration with biopharma companies. With MERIT your study data and images can easily be shared between clinical sites, reading centers, CROs, and Sponsors for maximum transparency. This makes managing global trials involving multipl...
MERIT's Ophthalmic Clinical Expertise
Просмотров 12710 месяцев назад
MERIT's Ophthalmic Clinical Expertise
MERIT's Clinical Endpoint Evaluation & Expertise
Просмотров 5910 месяцев назад
MERIT's Clinical Endpoint Evaluation & Expertise
AI integration in Radiology Clinical Practice Webinar
Просмотров 32 тыс.Год назад
AI integration in Radiology Clinical Practice Webinar
MERIT Webinar: Validating Your Imaging Data to Secure Funding
Просмотров 3,6 тыс.Год назад
MERIT Webinar: Validating Your Imaging Data to Secure Funding
MERIT Webinar: Lugano and Oncology Imaging Endpoints
Просмотров 51 тыс.Год назад
MERIT Webinar: Lugano and Oncology Imaging Endpoints
MERIT Webinar: PCWG3 and Oncology Imaging Endpoints
Просмотров 3,1 тыс.Год назад
MERIT Webinar: PCWG3 and Oncology Imaging Endpoints
MERIT Fundamentals of iRECIST and Imaging Endpoints Webinar
Просмотров 1,3 тыс.Год назад
MERIT Fundamentals of iRECIST and Imaging Endpoints Webinar
MERIT Webinar: RANO Oncology Trial Endpoints
Просмотров 10 тыс.Год назад
MERIT Webinar: RANO Oncology Trial Endpoints
MERIT Webinar: How an Imaging Core Lab Can Help Overcome Common Study Challenges
Просмотров 13 тыс.2 года назад
MERIT Webinar: How an Imaging Core Lab Can Help Overcome Common Study Challenges
MERIT Webinar: RECIST 1.1 & Oncology Trial Endpoints
Просмотров 8 тыс.2 года назад
MERIT Webinar: RECIST 1.1 & Oncology Trial Endpoints
He basically read aloud the RESIST 1.1 paper, but on a slide.
can I use RECIST 1.1 if no baseline studies are available? I often receive cases with no pretreatment images.
Hi Dr. Gene Kim, It is such a great and informative presentation. Can you help me to share these slides ?
Thank you for the detailed tutorial. There is a grey area between various RANO versions. Contrast Wen 2010 vs the presentation at: 23:25 - PR oveall visit response requires Corticosteroid dose = *stable or* lower dose than baseline. 25:00 -- SD overall visit response requires Corticosteroid dose = stable or *lower* dose than baseline.
Thank you for this video! I am a Data Engineer from the Netherlands interested in medical imaging AI solutions, this video taught me a lot.
Good presentation!
😘 Promo SM
🌻
Muito interessante, aguça minha curiosidade.
42:40 what I have been wondered. I found the answer in there😂
𝖕𝖗𝖔𝖒𝖔𝖘𝖒